Table 2.
Year | Population | Cases | Crude Rate | ASIR | 95% CI |
---|---|---|---|---|---|
Melanoma (Including In Situ Melanoma) | |||||
2008 | 7,298,313 | 792 | 10.85 | 11.56 | [11.38–11.75] |
2009 | 7,416,605 | 751 | 10.13 | 10.80 | [10.62–10.97] |
2010 | 7,462,044 | 727 | 9.74 | 10.35 | [10.18–10.52] |
2011 | 7,501,853 | 773 | 10.30 | 10.88 | [10.7–11.06] |
2012 | 7,515,398 | 809 | 10.76 | 11.25 | [11.07–11.43] |
2013 | 7,478,968 | 887 | 11.86 | 12.30 | [12.11–12.49] |
2014 | 7,433,894 | 887 | 11.93 | 12.23 | [12.05–12.43] |
2015 | 7,424,754 | 1019 | 13.72 | 13.86 | [13.65–14.06] |
2016 | 7,448,332 | 1064 | 14.29 | 14.34 | [14.14–14.55] |
2017 | 7,496,276 | 1044 | 13.93 | 13.78 | [13.57–13.98] |
Invasive melanoma | |||||
2008 | 7,298,313 | 560 | 7.67 | 8.19 | [8.04–8.35] |
2009 | 7,416,605 | 517 | 6.97 | 7.38 | [7.23–7.52] |
2010 | 7,462,044 | 481 | 6.45 | 6.83 | [6.7–6.98] |
2011 | 7,501,853 | 543 | 7.24 | 7.64 | [7.49–7.79] |
2012 | 7,515,398 | 556 | 7.40 | 7.73 | [7.58–7.88] |
2013 | 7,478,968 | 616 | 8.24 | 8.57 | [8.41–8.73] |
2014 | 7,433,894 | 585 | 7.87 | 8.04 | [7.89–8.2] |
2015 | 7,424,754 | 683 | 9.20 | 9.23 | [9.06–9.4] |
2016 | 7,448,332 | 698 | 9.37 | 9.32 | [9.16–9.49] |
2017 | 7,496,276 | 618 | 8.24 | 8.08 | [7.92–8.24] |
Abbreviations: ASIR, age-standardised incidence rate.